SGK1 and breast carcinoma: For example, Sommer et al. (2013) reported that resistance to AKT inhibitors was determined by elevated activation of SGK1 and NDRG1 in breast cancer cells and that AKT inhibitor-resistant cells ceased expanding when SGK1 was silenced via shRNA-induced knockdown.